1.Two cases of emphysematous pyelonephritis
Jae Kyu KIM ; I Ho YOON ; Yng Ki CHUNG ; Byung Sik NAH ; Hyon De CHUNG
Journal of the Korean Radiological Society 1985;21(6):1012-1016
Emphysematous pyelonephritis is rare but freuently fatal complication of renal parenchymal infection, mostcommonly occurs in diabetic patients and is often associated with urinary obstruction, prior urologicalabnormality or infection. From 1898 to 1984 , about 50 cases of empysematous pyelonephritis have been reporteduniversally. The diaignosis of emphysematous pyelonephritis can be made only roentgenographically. In the last 2years, we have had two cases of emphysematous pyelonephritis at our hospital. It is our purpose to report twopatients who have survived wtih a brief review of the previous literature.
Humans
;
Pyelonephritis
2.Expression of Ids in Preimplantation Mouse Embryos.
Seok Ho HONG ; Hee Young NAH ; Young Jin LEE ; Ji Won LEE ; Young Soo SON ; Hee Dong CHAE ; Sung Hoon KIM ; Byung Moon KANG ; Chung Hoon KIM
Korean Journal of Fertility and Sterility 2004;31(4):201-208
OBJECTIVE: The Id family of helix-loop-helix proteins are thought to affect the balance between cell growth and differentiation by negatively regulating the function of basic-helix-loop-helix (bHLH) transcriptional factors. The aim of this study was to investigate the expression pattern of Ids (Id-1,-2,-3, and -4) in preimplantation mouse embryos at mRNA and protein levels. METHODS: Oocytes and preimplantation embryos were collected from reproductive organs of female ICR mice following superovulation. RT-PCR was performed to investigate the mRNA expression patterns of Id genes and their protein were localized by immunofluorescence analysis. RESULTS: Id-1 and Id-3 mRNAs were strongly expressed at the germinal vesicle (GV) oocyte and the blastocyst stages. Id-2 mRNA was expressed throughout preimplantation embryo development, but Id-4 was not expressed. Immunofluorescence showed that Id-1 and Id-2 were predominantly localized in cytoplasmic region, but the immunofluorescence signal of Id-3 was weak throughout preimplantation embryo development. CONCLUSION: These data show for the first time that Ids are expressed in preimplantation mouse embryos and suggest that Ids may play an important role in early preimplantation embryo development and uterine physiological changes.
Animals
;
Blastocyst
;
Cytoplasm
;
Embryonic Development
;
Embryonic Structures*
;
Female
;
Fluorescent Antibody Technique
;
Humans
;
Mice*
;
Mice, Inbred ICR
;
Oocytes
;
Pregnancy
;
RNA, Messenger
;
Superovulation
3.Results of Curative Radiotherapy Alone in Patients with Uterine Cervical Carcinomas.
Taek Keun NAM ; Byung Sik NAH ; Sung Ja AHN ; Woong Ki CHUNG ; Ho Seon CHOI ; Yoon Kyeong OH
Cancer Research and Treatment 2002;34(5):365-371
PURPOSE: To evaluate the role of curative radiotherapy alone in the treatment of uterine cervical carcinomas, by a retrospective analysis with respects to survival and pelvic control, and to find any risk factors of failure MATERIALS AND METHODS: Between Jan. 1990 and Dec. 1995, a total of 187 patients, diagnosed with uterine cervical carcinomas in FIGO stages greater than IA, were treated by curative radiotherapy alone with no chemotherapy. The ages of the patients ranged from 26 to 80 years, with a median of 60 years. The number of patients diagnosed with squamous cell carcinomas were 183 (97.9%). The number of patients with FIGO stage IB1, IB2, IIA, IIB, IIIA, IIIB and IVA were 61 (32.6%), 7 (3.7%), 43 (23.0%), 62 (33.3%), 3 (1.6%), 7 (3.7%) and 4 (2.1%), respectively. External radiotherapy was performed with 6 MV or 10 MV X-rays, with a dose range of 19.8 Gy~ 50.4 Gy (median; 30.6), to whole pelvis. Intracavitary radiation (ICR) was then performed using a high-dose rate remote controlled afterloader with radioisotopes of Co-60 and Cs-137. The fraction size of the ICR was 5 Gy twice a week, and was delivered up to total doses of 10 Gy~ 55 Gy (median; 40). After the ICR, additional pelvic external radiotherapy with midline shielding width of 4 cm was performed with the dose range of 0~30.6 Gy (median; 19.8), and the resultant total doses of A points ranged between 49.8 Gy and 86.0 Gy (median; 70.6). RESULTS: The five-year overall survival rates of FIGO IB1, IB2, IIA, IIB, III and IVA were 88.3%, 83.3%, 86.1%, 65.2%, 60.0% and 50.0%, respectively (p=0.005). The pelvic control rates of each stage were 90.1%, 85.7%, 86.1%, 69.4%, 68.6% and 50.0%, respectively (p=0.03). From the multivariate analysis, the radiation response and tumor diameter were found to be significant factors affecting the overall survival. The significant factors influencing pelvic control were the radiation response and pre-treatment hemoglobin level. CONCLUSION: The radiation response and tumor diameter were significant factors affecting survival, so patients with tumor diameters greater than 4 cm should be considered for a combined modality, such as concurrent chemoradiotherapy.
Carcinoma, Squamous Cell
;
Chemoradiotherapy
;
Drug Therapy
;
Humans
;
Multivariate Analysis
;
Pelvis
;
Radioisotopes
;
Radiotherapy*
;
Retrospective Studies
;
Risk Factors
;
Survival Rate
4.Influence of Transforming Growth Factor-alpha on Expression of Matrix Metalloproteinase-2, 9 and Epidermal Growth Factor Receptor Gene in the Mouse Blastocysts.
Jeong Hee KIM ; Seok Ho HONG ; Hee Young NAH ; Ji Yun LEE ; Hee Dong CHAE ; Chung Hoon KIM ; Byung Moon KANG ; In Ha BAE
Korean Journal of Fertility and Sterility 2001;28(3):173-182
No abstract available.
Animals
;
Blastocyst*
;
Epidermal Growth Factor*
;
Matrix Metalloproteinase 2*
;
Mice*
;
Receptor, Epidermal Growth Factor*
5.Irradiation alone in Stage IB , IIA and IIB Cervix Cancer: 2 Correlation between Treatment Factors and Pelvic Tumor Control.
Sung Ja AHN ; Woong Ki CHUNG ; Byung Sik NAH ; Taek Keun NAM ; Ho Sun CHOI ; Ji Soo BYUN
Journal of the Korean Cancer Association 1998;30(2):321-328
No abstract available.
Cervix Uteri*
;
Female
;
Uterine Cervical Neoplasms*
6.2 Cases of Spontaneous Esophageal Perforation (Boerhaave Syndrome).
Young Min KIM ; Kyu Nam PARK ; Won Jae LEE ; Byung Ho NAH ; Kwan Mo YANG ; Seung Pil CHOI ; Jae Gil PARK ; Se Kyung KIM
Journal of the Korean Society of Emergency Medicine 1997;8(4):617-623
We experienced two cases of Boerhaave syndrome (spontaneous esophageal rupture). The first patient was a 62-year-old male who presented epigastric pain after several violent vomitings associated with alcohol ingestion. Diagnosis was done early and promptly in our emergency center and then definitive treatment was done only after 12hrs from onset of his symptom and he was discharged in relatively good condition 256ays after his admission. The second patient was a 44-year-old male who was transfered to our emergency center with chest pain, dyspnea and fever after vomitings associated with autobicycle accident. Diagnosis was delayed due to initial trauma oriented evaluation and incidious develpement of typical clinical findings and then he was managed conservatively but he died of multiple organ failure due to sepsis. We report these cases with literature review.
Adult
;
Chest Pain
;
Diagnosis
;
Dyspnea
;
Eating
;
Emergencies
;
Esophageal Perforation*
;
Fever
;
Humans
;
Male
;
Middle Aged
;
Multiple Organ Failure
;
Sepsis
7.Results of Postoperative Irradiation in Patients with Carcinoma of Uterine Cervix Stage IB and IIA.
Sung Ja AHN ; Taek Keun NAM ; Woong Ki CHUNG ; Byung Sik NAH ; Ho Sun CHOI ; Ji Soo BYUN
Journal of the Korean Society for Therapeutic Radiology 1995;13(1):41-48
PURPOSE: The adjuvant postoperative radiotherapy has been usually applied to the patients with unfavorable prognostic factors after radical operation in early cervical cancer. We focused on the evaluation of the survival status and failure patterns of the patients with postoperative radiotherapy. MATERIALS AND METHODS: We retrospectively analyzed ninety patients with FIGO stage IB and IIA cervix cancer who received postoperative pelvic irradiation at Chonnam University Hospital between August 1985 and December 1988. Seventy-eight patients had adequate follow-up information for survival anlysis. Median follow-up time of these patients was 64 months. RESULTS: The 5 year overall and disease free survival rate of ninety patients was 80.0% and 80.2% respectively. The prognostic significance to the survival was determined by multivariate analysis. Adequacy of resection margin(p=0.005) and lymph node status(p=0.005) appeared to be independent prognostic factors. Recurrence occurred in 13 Patients, 5 in the pelvis and 8 at distant sites. He median time to recurrence was 19 months(range;3-39 months). The pelvic recurrence was more prevalent in the group of patients with adenocarcinoma, depth of stromal invasion more that 10mm and use of chemotherapy. The distant failure was more prevalent in the group of positive resection margin or positive lymph node with statistical significance. CONCLUSION: Patients with pelvic lymph node or surgical margin involvement clearly constitute a high risk group in this analysis and should be considered as candidates for some form of adjuvant therapy.
Adenocarcinoma
;
Cervix Uteri*
;
Disease-Free Survival
;
Drug Therapy
;
Female
;
Follow-Up Studies
;
Humans
;
Jeollanam-do
;
Lymph Nodes
;
Multivariate Analysis
;
Pelvis
;
Radiotherapy
;
Recurrence
;
Retrospective Studies
;
Uterine Cervical Neoplasms
8.Significance of p53 Immunoreactivity in Squamous Cell Carcinoma of the Cervix Treated with Radiotherapy Alone.
Sung Ja AHN ; Ho Sun CHOI ; Chan CHOI ; Byung Sik NAH ; Woong Ki CHUNG ; Taek Keun NAM
Journal of the Korean Cancer Association 2001;33(2):106-112
PURPOSE: We undertook this study to evaluate the significance of p53 immunoreactivity in squamous cell carcinoma of the cervix, treated with radiotherapy alone. MATERIALS AND METHODS: Immunohistochemical staining of p53 proteins were performed in eighty patients with squamous cell carcinoma of the cervix, and who completed curative radiotherapy between Jan. 1996 and Apr. 1998 at the Department of Therapeutic Radiology, Chonnam National University Hospital. External- beam radiotherapy was combined with intracavitary brachytherapy. Results were analyzed for the end points of pelvic tumor control and distant failure rates. The follow-up time ranged from 7 to 58 months with a median of 40 months. RESULTS: p53 positive and negative groups involved 45 and 35 patients, respectively, and the positive p53 immunoreactivity rate was 56% (45/80). p53 immunoreactivity showed no significant correlation with age, tumor size, serum tumor marker (SCC), or HPV18 expression, while there was a statistically marginally significant correlation with HPV16 expression. The pelvic tumor control rate of the p53 positive group was 87% and that of p53 negative group was 83% (0.05). The other parameters influencing negatively to the pelvic tumor control and with statistical significance were tumor ulceration and barrel type. Multivariate analysis also showed that p53 immunoreactivity had no prognostic value for pelvic tumor control of the disease, and that the statistically significant factor was tumor ulceration. The treatment failure rate of the p53 positive group was 23% and that of the negative group was 26% (p>0.05). CONCLUSION: p53 immunoreactivity in the cervix cancer stage IB, II patients seems to have no value as a predictor of tumor behavior after curative radiotherapy.
Brachytherapy
;
Carcinoma, Squamous Cell*
;
Cervix Uteri*
;
Female
;
Follow-Up Studies
;
Humans
;
Jeollanam-do
;
Multivariate Analysis
;
Radiation Oncology
;
Radiotherapy*
;
Treatment Failure
;
Ulcer
;
Uterine Cervical Neoplasms
9.Irradiation Alone in Stage IB, IIA, and IIB Cervix.
Sung Ja AHN ; Woong Ki CHUNG ; Byung Sik NAH ; Taek Keun NAM ; Ho Sun CHOI ; Ji Soo BYUN
Journal of the Korean Society for Therapeutic Radiology 1997;15(2):129-136
PURPOSE: We analyzed the survival and failure patterns of cervix cancer patients treated with irradiation alone to evaluate our treatment method and to compare with the others. METHODS AND MATERIALS: Two hundred and twenty cervical cancer patients, Stage IB, IIA, and IIB who completed the planned treatment between May 1987 and December 1991 were analyzed retrospectively. The Stage IB patients were restaged to the Stage IB1 and IB2 by the recently revised FIGO classification. Patients were treated with a combination of external irradiation and the intracavitary brachytherapy. Determination of the tumor control was done at the time of 6 months postirradiation. The follow-up time was ranged from 3 to 115 months and the mean was 62 months and the follow-up rate was 93.6%(206/220). RESULTS: The overall 5-year survival rate of Stage IB1(N=50), IB2(N=15), IIA(N=58), and IIB(N=97) was 94%, 87%, 69%, and 56%, respectively. In the univariate analysis of prognostic factors,stage(0.00), initial Hg level (p=0.00), initial TA-4(tumor-associated) antigen level(p=0.02), initial CEA level(p=0.02), barrel-shaped tumor(p=0.02), whole cervical involvement (0.00), pelvic lymphadenopathy(LAP) in CT(p=0.04), and post-irradiation adjuvant chemotherapy(p=0.00) were statistically significant in survival analysis. In a while, multivariate analysis showed that the stage was the most powerful prognostic indicator and the post-irradiation chemotherapy factor also showed the statistical significance. The overall local control rate was 81% and by the stage, 100% in Stage IB1, 86.7% in Stage IB2, 84.5% in Stage IIA, and 68.1% in Stage IIB, respectively. The overall tumor recurrence rate was 15.5%(27/174) and by the stage, 8%(4/50) in Stage IB1, 0%(0/13) in Stage IB2, 22.4%(11/49) in Stage IIA, and 19.4%(12/62) in Stage IIB, respectively. CONCLUSIONS: We obtained the similar treatment results to the other's ones in early stage cervical cancer patients. But in Stage IIB, the local control rate was lower than that of the other institutes and also the survival was poorer. So it seems to be necessary to reevaluate the treatment method in advanced cervical cancer patients.
Academies and Institutes
;
Brachytherapy
;
Cervix Uteri*
;
Classification
;
Drug Therapy
;
Female
;
Follow-Up Studies
;
Humans
;
Multivariate Analysis
;
Radiotherapy
;
Recurrence
;
Retrospective Studies
;
Survival Rate
;
Uterine Cervical Neoplasms
10.Acute Gastric Volvulus due to Diaphragmatic Hernia.
Ju Hee MAENG ; Hee Sup LEE ; Jin Gun JANG ; Bae Gun PARK ; Byung Kyu NAH ; Yong Ho KIM ; Sung Moon JUNG ; Gab Jin CHEON
The Korean Journal of Gastroenterology 2003;42(6):544-548
Gastric volvulus is an uncommon condition which is difficult to diagnose and treat. It designates abnormal rotation of the stomach along its longitudinal (organoaxial) or transverse (mesenteroaxial) axis. When the rotation exceeds 180 degrees, gastric obstruction or strangulation may occur. The classical presentation of acute gastric volvulus is the triad of severe epigastric pain, vomiting followed by retching without the ability to vomit, and difficulty or inability to pass a nasogastric tube. Delay in diagnosis and treatment of gastric volvulus can lead to fatal complications such as gastric ischemia, perforation, and hemorrhage. Gastric volvulus is a true emergency which should be treated immediately either surgically or by upper endoscopy. We report a case of an acute incarcerated gastric volvulus due to a left-sided diaphragmatic hernia in an adult male patient, which was treated successfully by operation.
Acute Disease
;
Hernia, Diaphragmatic/*complications
;
Humans
;
Male
;
Middle Aged
;
Stomach Volvulus/diagnosis/*etiology